About the Authors
- Simone Lanini
-
* E-mail: simone.lanini@inmi.it
Affiliation Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases “Lazzaro Spallanzani”, Rome, Italy
- Alessandro Nanni Costa
-
Affiliation Italian National Transplant Center, Italian National Institute of Health (ISS), Rome, Italy
- Vincenzo Puro
-
Affiliation Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases “Lazzaro Spallanzani”, Rome, Italy
- Francesco Procaccio
-
Affiliation Italian National Transplant Center, Italian National Institute of Health (ISS), Rome, Italy
- Paolo Antonio Grossi
-
Affiliation Division of Infectious Diseases, Department of Surgical and Morphological Sciences, University of Insubria-Ospedale di Circolo, Varese, Italy
- Francesca Vespasiano
-
Affiliation Italian National Transplant Center, Italian National Institute of Health (ISS), Rome, Italy
- Andrea Ricci
-
Affiliation Italian National Transplant Center, Italian National Institute of Health (ISS), Rome, Italy
- Sergio Vesconi
-
Affiliation Direzione Generale Salute Lombardia, Regione Lombardia, Milan, Italy
- Michael G. Ison
-
Affiliation Divisions of Infectious Diseases & Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
- Yehuda Carmeli
-
Affiliation Division of Epidemiology and the Laboratory for Molecular Epidemiology and Antibiotic Research, Sourasky Medical Center, Tel Aviv, Israel
- Giuseppe Ippolito
-
Affiliation Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases “Lazzaro Spallanzani”, Rome, Italy
- Donor-Recipient Infection (DRIn) Collaborative Study Group
-
¶Members of Donor-Recipient Infection DRIn Collaborative Study Group is provided in the Acknowledgments.
Competing Interests
Yehuda Carmeli, received grants, honoraria, travel support, consulting fees, and other forms of financial support. Paolo Antonio Grossi received grants, honoraria, travel support, consulting fees, and other forms of financial support from Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag, Merck Sharp & Dohme, Novartis, Pfizer, Roche.Michel G Ison: received research support from Anolinx, Cellex, Chimerix, Crucell, GlaxoSmithKlein, NexBio and ViroPharma; provided paid consultation to Alios, Abbott, Crucell and Genentech/Roche; provided unpaid consultation to Adamas, BioCryst, Biota, Cellex, Clarassance, GlaxoSmithKlein, GenMarkDx, Romark, Toyama/MediVector, NexBio, Theraclone, Vertex and Visterra; participated to data and safety monitoring board for Biota and NexBio. The other authors declare that they have no competing interests. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SL FP GI VP ANC AR FV PAG SV. Analyzed the data: SL FP GI MGI PAG. Contributed reagents/materials/analysis tools: AR SV FV FP ANC. Wrote the paper: SL MGI YC GI.